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Abstract
The under-representation of culturally and linguistically diverse participants in clinical trials is an ongoing concern
for medical researchers and the community. The aim of this review is to examine the complex issue of recruiting
culturally and linguistically diverse (CALD) older people to medical research and to examine responses to these
issues. The review focuses on (1) trends in the existing literature on barriers to and strategies for recruiting CALD
and older people to clinical research, (2) issues with informed consent for CALD populations, and (3) the efficacy of
innovative approaches, including approaches incorporating multimedia in research and consent processes. The
literature indicates that predominant barriers to greater involvement of CALD patients in clinical trials are
communication, including literacy and health literacy considerations; English language competence; and cultural
factors in the research setting such as mistrust of consent processes, as well as considerable practical and logistical
barriers, including mobility considerations. Some evidence exists that incorporating multimedia resources into the
informed consent process can improve patient understanding and is preferred by patients, yet these findings are
inconclusive. A multi-methodological approach, including the use of culturally and linguistically sensitive
multimedia tools, may help address the issue of low inclusion of CALD groups in clinical research. Researcher
education needs to be taken into account to address preconceptions about CALD resistance to research
participation and to raise awareness of cultural concerns in regard to research participation.
Keywords: CALD, Informed consent, Clinical research, Older people, Migrants, Language, Health literacy,
Recruitment, Multimedia, Low English proficiency
Background
Elderly people of culturally and linguistically diverse
(CALD)1 backgrounds are under-represented in clinical
research [1–3]. Under-representation of CALD patients
is problematic for several reasons, but the problems
centre on the decreased generalisability of trial findings
and equity for patients in accessing the benefits of par-
ticipating in trials. First, the generalisability of research
findings is compromised [2, 4, 5], and the potential ef-
fects of variation in the pathobiology of disease, diet and
lifestyle, both positive and negative, may go undetected,
as do factors such as race-related differences in drug
responses [3]. Some health problems are more prevalent
among particular minority groups, and a disparity exists
in health outcomes according to ethnicity [6] and be-
tween minorities and non-minorities [2]. Another con-
cern is that healthcare provision is not equal to all [7, 8];
people who participate in research may receive better care
and have better health outcomes [9]. The disadvantaged
sectors of the population can be excluded from the poten-
tial benefits of trial participation [10], which can provide
newer, higher-quality or specialised care and monitoring
that is made available to participants in trials [11].
The necessity of including older people from minority
groups in clinical research will intensify given that older
people are a fast-growing segment of the population
worldwide [12]. In 2012, in Australia, people aged 65
years and over constituted 14 % of the population, but
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the proportion is projected to increase to 22 % in 2061,
and to 25 % in 2101 [13]. Currently, people from a
CALD background make up a substantial proportion of
Australia’s ageing population, with over 20 % of people
older than 65 years of age having been born outside of
Australia, and in just a few years’ time, by 2021, that fig-
ure will rise to 30 % [14].
Policy promoting equitable inclusion in clinical trials
There is a call for health inequalities to be addressed, for
research to focus on underrepresented groups [11, 15,
16], and for strategies to be developed to encourage the
participation of these groups [7]. Over the past two de-
cades, many studies have aimed to determine the bar-
riers to minority groups participating in clinical research
[3, 4, 17–20] and, more specifically, elderly ethnic mi-
nority groups [2, 21–23]. This is particularly notable in
the United States, where legislation in 1993 has subse-
quently required the inclusion of women and ethnic mi-
norities in research [24]. In Australia, no legislation
explicitly requires the inclusion of these traditionally
under-represented populations in clinical research, but
the National Statement on Ethical Conduct in Human
Research [25] states that all research should be ‘just’.
This includes ensuring that, under section 1.4:
(a)…the selection, exclusion and inclusion of research
participants is fair…
(b) there is no unfair burden of participation in
research on particular groups; …
(d) there is fair distribution of the benefits of
participation in research [25].
In addition, one of the primary goals of the Australian
government’s National Ageing and Aged Care Strategy
for People from Culturally and Linguistically Diverse
(CALD) Backgrounds is better practice through improv-
ing research and data collection mechanisms that are in-
clusive of the ageing CALD population [14].
Health literacy and ethnicity
A known correlation exists between the level of health lit-
eracy and ethnicity, with minority populations suffering
from lower levels of health literacy than the general popu-
lation [11]. Furthermore, people with low English profi-
ciency (LEP) have been shown to be disadvantaged in the
informed consent process, scoring lower in measures of
informed consent than fluent English speakers [26]. Lower
health literacy is strongly associated with less engagement
with health care and, thus, poorer health outcomes [27].
Available health education materials are often not literacy-
level appropriate [27–29]. In Australia, only 33 % of the
overseas-born population has ‘adequate or better’ health
literacy compared to 43 % of the Australian-born popula-
tion, and the figures are lower for more recent arrivals
(27 %) and for people whose first language is not
English (26 %) [30]. Participating in a clinical trial is one
health-related decision people from a CALD background
may make in their lifetime, and evidence exists that the
under-representation of CALD patients in clinical re-
search is partly due to a limited awareness and under-
standing of research opportunities and processes [11].
This review
Providing appropriate information to research participants
is central to good clinical research practice [16, 31, 32] but
presents challenges in approaching CALD patients. In
cases where CALD patients do not speak English or have
LEP or literacy, they are often not approached about par-
ticipating. This occurs for two reasons: first, inadequate
evidence is available on effective strategies for recruiting
CALD patients, and second, research funding rarely
covers the costs of developing CALD strategies.
While positive intent exists on the part of govern-
ments and the health sector to address the issue of low
participation of CALD groups and while advances have
been made in terms of identifying barriers and useful
strategies associated with inclusion, minority groups are
still not well represented in clinical trials [1, 9, 33]. This
review examines current barriers to and strategies for in-
volving CALD patients in clinical research, as well as the
issues associated with informed-consent procedures in
this group and the strategies that have been used to try
to overcome these barriers. We also examine the out-
comes of interventions trialling multimedia for the
research-consent process in both English speakers and
CALD patients in order to assess the feasibility of adapt-
ing such technologies for older CALD people.
Methods
The key research areas under review are studies focused
on the following:
 Identifying barriers and developing strategies to
overcome the lack of inclusion of CALD groups in
medical research
 Identifying barriers and developing strategies to
overcome the lack of inclusion of older people in
medical research
 Improving the informed consent process
 The use of multimedia aids in the informed consent
process
We conducted a search in MEDLine in May 2015, and
no results were returned for the defined topic of improv-
ing the informed consent process to improve CALD
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participation in clinical research utilising methods incorp-
orating multimedia technology (e.g. computers, video, and
tablets/iPads). The lack of studies trialling innovative
methods of obtaining informed consent in populations
where English language proficiency is low has been com-
mented on in the past. For example, Hendrickson [34]
found no documented use of videotape recruitment of
non-English-speaking participants prior to her study. The
dearth of existing reports examining the use of tablets in
clinical trial research has also been noted [35].
In response to this finding, we then broke the research
topics down into their components to be examined sep-
arately: research on the participation of CALD groups in
medical research, research on the participation of older
people in medical research (CALD and the elderly in
general), studies on informed consent in a CALD con-
text, and multimedia use in a research informed consent
context. Combinations of the following terms were used
in the search query: ‘informed consent’ AND/OR ‘mi-
grants’, ‘minorities’, ‘low English proficiency’, ‘multimedia’,
‘elderly’, ‘iPad’, ‘video’, and ‘computer’.
Findings
Barriers to the inclusion of elderly CALD people in clinical
trials
The major themes consistently identified by researchers
as barriers to CALD participation in clinical research
are: (1) mistrust; (2) communication barriers, including
the complexity of written documents, language/literacy
issues and lack of perceived benefit; (3) cultural barriers,
including competing cultural beliefs/practices concern-
ing health; (4) economic and time constraints; (5) mobil-
ity issues and health issues; and (6) opportunity barriers.
Mistrust
Mistrust is a commonly cited barrier to inclusion, mani-
festing in a number of ways: mistrust of mainstream so-
ciety [6], of the scientific community or of research
institutions [23], perhaps due to awareness of unethical
practices on the part of the medical research community
in the past [2, 6, 36], or a perception that academic insti-
tutions are elitist and not committed to the welfare of
ethnic minority communities [17]. Alternatively, the
mistrust may be directed towards the general healthcare
system or be culturally generated, as for example when
the medical practices of the culture of origin differ sub-
stantially to those of mainstream Western physicians [6].
Mistrust issues may be more pronounced among the
elderly [37] who, because of increased frailty, can feel
more vulnerable to potential exploitation [2].
Communication barriers
Language is an evident communication barrier in CALD
groups [6]. Communication barriers also include issues
associated with complex forms and informed consent pro-
cedures [38, 39], which are amplified for people with lim-
ited English language and/or low literacy [28]. Achieving
true informed consent, even amongst those for whom
English is a first language, can be difficult [28, 39, 40].
Much debate has occurred on the comprehensibility of
participant information forms, which are often notoriously
lengthy and require a high (often tertiary) level of reading
comprehension [17, 41–43]. Ensuring that a patient un-
derstands to what he/she is consenting becomes even
more problematic in the presence of CALD barriers.
While ensuring informed consent is paramount, the
process of obtaining consent may end up having the un-
desired effect of creating barriers by arousing suspicion,
promoting mistrust, and causing misunderstanding, which
may ultimately discourage participation [44].
Failing to communicate research findings with commu-
nities is also a known barrier [23]. Among the many rea-
sons for low success in clinical trial recruitment in general
is a ‘perceived lack of information about the purpose, pro-
cedures and value of clinical trials that [patients] have
been asked to contribute to’ (p. 111) [45]. This issue has
been highlighted in studies on the elderly [37, 46].
Cultural barriers
Cultural barriers to research recruitment include in-
appropriate information provision [10], unsuitable data
collection and assessment measures [47, 48], cultural
stigmas associated with illness, and a lack of social pres-
ence in the communities [1]. Specifically, for older
CALD people, a lack of cultural diversity amongst re-
search staff can act as a barrier to CALD participation;
conversely ‘race matching’ (alignment of the race of the
patient and researcher) may enhance participation [23,
49]. Beliefs about health and health care can vary signifi-
cantly according to different cultures [8, 50] and may
clash with the prevailing norms in the mainstream soci-
ety in question, making individuals from CALD back-
grounds less likely to explore all the healthcare options
available to them.
Important cultural considerations have been identified
in the consent process. Obtaining written informed con-
sent from research participants remains standard prac-
tice [25]. However, it may be inappropriate to seek
written consent from participants of certain cultures
[49]. Killawi and colleagues [48] identified potential
problems with obtaining signed, written consent, includ-
ing an association with formal transactions, the arousal
of suspicion or concern, the potential for threat for
illiterate persons, or the implication of a lack of trust.
Another factor undermining signed written consent is
the possibility of the request for a signature being
perceived as insulting if one’s word has already been
given [51].
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Economic and time constraints
CALD status and lower socioeconomic status are two
factors that are often connected [9], and socioeconomic
constraints have been cited by many researchers as bar-
riers to recruitment of CALD participants in medical re-
search [6, 10, 52, 53]. Time constraints, including those
connected with family and job responsibilities, are also
preventive factors in study participation [20, 53].
Mobility and health issues
Restrictions required by religious or cultural precepts
may mean that women in some CALD groups may have
compromised mobility resulting from their dependence
on their husbands or another male relative for transpor-
tation [48]. For the elderly in general, additional mobility
barriers such as physical frailty, increased health issues,
and illness can make it difficult for this group to partici-
pate in clinical trials [22]. Common conditions such as
visual impairment or decreased manual dexterity can in-
hibit participation; for example, written documents are
more of a barrier [3, 54]. The elderly in general suffer
greater degrees of social isolation, making them a less
accessible group [2, 37].
Opportunity barriers
Barriers are also created for CALD groups by the research
process. These factors are important, since they determine
whether or not a person is given the opportunity to par-
ticipate in research at all. For example, people with LEP or
low levels of literacy are routinely excluded from many
clinical trials because they are viewed as unable to provide
truly informed consent [6, 41]. Most research protocols
do not engage with language proficiency at all [55]. Fur-
thermore, when clinicians believe the costs or burden of
data collection are too great, they are less likely to refer or
recruit patients to clinical trials [56]. In a systematic re-
view of studies on recruitment of underrepresented
groups into clinical trials, 11 studies out of 18 found clin-
ician attitudes were a barrier to enrolment, whereas only
three of these studies found clinician attitudes to be an en-
abler [56]. Provider attitudes that hindered patient recruit-
ment related to patient age, comorbidities, disease stage,
and/or a perception of patient mistrust of researchers.
In another review of studies examining barriers to re-
cruitment of underrepresented populations in clinical
trials, Ford et al. found that the most commonly re-
ported barriers related to the opportunity to participate
in trials [10]. Potential participants were excluded from
trials because of factors such as age, socioeconomic
status, ethnic minority status, and comorbid condi-
tions. This study also identified provider attitudes and
eligibility criteria as the most frequently reported bar-
riers to participation.
Overcoming the lack of inclusion of elderly CALD in
clinical research
This section presents reported interventions and strat-
egies to help overcome barriers impeding the inclusion
of CALD groups in general, and from elderly people
from a CALD background specifically, in clinical re-
search. Strategies are presented thematically, in response
to the barriers discussed above. These interventions are
summarised in Table 1.
Community relationship building and outreach
Establishing and building trust is paramount in any en-
deavour to enrol and retain members of minority groups
in clinical research. A key strategy for doing this is
through developing relationships within the community
of the target group [57]. This can be through establish-
ing and maintaining a relationship with a community
advisory board [3], so-called ‘gatekeepers’, such as family
members or housing managers and enrolling them in
the evaluation of the research opportunity, building coa-
litions, and partnering with physicians who provide care
for the populations to be included in the trial [17, 46],
thereby establishing a rapport with trusted and promin-
ent members of the community such as community or
religious leaders [6, 17, 58] and other potential referral
sources [18, 57].
Becoming more involved with the community by at-
tending events [1] and committing to support the com-
munity in ways that the community values are effective,
even essential, strategies [6, 58] for building trust and
demonstrating a genuine motivation to help the commu-
nity. The maintenance of ongoing connections is also
necessary [59], especially with community leaders [58].
This is important as a trust-building exercise in the con-
text of ongoing research studies. Involving the commu-
nity in study design and implementation [15, 22], while
utilising, for example, community-based participatory re-
search frameworks [19, 59] recognises that communities
contribute knowledge to the process, which in turn helps
with the formulation of recruitment strategies and encour-
ages the involvement of minority community groups [23].
Communication–initial and ongoing
Providing education about the purposes of medical re-
search is an important strategy [18]. Santoyo-Olsseen et
al. [19] credit much of their success in recruiting lower so-
cioeconomic and/or CALD adults to a diabetes risk-
reduction program to their efforts to provide health edu-
cation and raise awareness in the target community prior
to study recruitment. Other educational strategies include
providing training for key community representatives [15]
or conducting community information sessions [47]. En-
suring that participants are aware of potential benefits of
participation also enhances the likelihood of participation
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[3, 17], and making sure participants agree with the
benefits to themselves and their community and com-
municating research outcomes have been shown to
create more favourable conditions for the participa-
tion of minority groups in medical research [6, 18].
Appealing to participants’ curiosity about their own
health can be a helpful engagement strategy [57]. It is
important to ensure there is a process of follow-up
and that participants are given feedback about or
summaries of the study results [17, 18, 23, 57].
Making forms and materials available in the target
group’s language(s) helps in overcoming language bar-
riers [17]–provided the translation protocol ensures cul-
tural and literacy-level appropriateness [29]. Explaining
the research process in a simple, appropriate, and sys-
tematic way can help to alleviate concerns regarding low
literacy and unfamiliarity with research [19]. Also, using
innovative materials and processes such as multimedia,
descriptive videos or illustrations can greatly enhance
the comprehension and retention of concepts [38, 47].
Table 1 Summary of the barriers to the inclusion of elderly participants who are culturally and linguistically diverse (CALD) in clinical
trials and the strategies that have been developed to overcome them
Barriers Strategies
1. Mistrust
• Of society, the scientific community, and research institutions,
and of the healthcare system
1. Community relationship building & outreach
• Enrol community gatekeepers in the research
• Build coalitions & partner with physicians
• Enrol trusted and prominent community members (community and
religious leaders)
• Make use of other referral sources
• Get involved with the community (attend events, etc.)
• Provide support to the community outside of research in ways that
are meaningful to the community
• Maintain connections with communities
• Involve the community in study design and implementation
2. Communication
• Low English proficiency
• Information presented is too complex
• Low health literacy
• Failure of researcher to communicate study rationale
• Failure of researcher to communicate research findings
2. Communication – initial & ongoing
• Provide education about health and medical research
• Provide training for key community representatives
• Provide community information sessions
• Explain potential benefits of participation
• Engage in follow up: provide feedback and study results to participants
• Provide translations of forms and materials
• Provide simple, appropriate, and systematic explanations of research
• Use innovative materials to enhance comprehension (e.g. video
presentations, animations).
• Simplify language and decrease content in consent documentation
• Apply user-friendly formatting and presentation (large graphics, both
visual and audio input)
3. Cultural
• Stigma
• Culturally inappropriate assessment measures
• Potential clash of beliefs around health care
• Potential alienation of participants if staff lack cultural diversity
• Potential issues with requiring signed written consent
3. Cultural sensitivity
• Be informed about the background and cultural circumstances of the
CALD group in question
• Use culturally appropriate language, symbolic gestures, and ideas.
• Respect differences
• Make provision for possible adaptations based on cultural differences
• Use bilingual/bicultural staff and staff reflective of the community
• Ensure consent process is culturally compatible/acceptable
(e.g. accept verbal consent if preferred by participant)
4. Economic & time constraints
• High likelihood of socioeconomic hardship
• Limited availability of participants
4. Facilitate access to research studies
• Take the research to the community
• Provide reimbursement for travel expenses
• Provide childcare
• Be flexible with scheduling
• Conduct research within the community/conduct home visits
• Provide transportation
5. Mobility
• Mobility may be restricted for cultural or religious reasons.
• In elderly populations, mobility may be a factor because of
increased frailty and/or impaired functionality.
5. Awareness raising amongst researchers and other stakeholders of
barriers to CALD participation
• Revisit and adapt consent processes for CALD groups
• Make study designs less rigid
6. Opportunity
• People with low English proficiency or literacy levels are often
excluded from trials.
• Clinicians attitudes are a strong barrier.
• If clinicians experience the costs or burden of data collection to
be high, they are less likely to recruit participants.
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Specifically, with regard to the consent process, simpli-
fying the language and content of forms and avoiding
repetition and redundancy have been identified as effect-
ive [39]; succinct, comprehensible material is preferable
to overloading a patient with detail, which may simply
be confusing. Stunkel and colleagues [60] found that
levels of comprehension did not differ for participants
who were randomly assigned to read either a ‘shorter,
more readable’ consent form compared to a longer,
standard consent form. Tymchuk et al. [61] found that
institutionalised elderly subjects benefited from simpli-
fied versions of forms more than from either storybook
presentations or videotape. Another study showed that
video education increased patients’ understanding of
consent information compared to oral education [62].
Formatting that presents information clearly (bullet
lists, adding section breaks, signposting definitions of
terms, and increasing font size for visually impaired
people) is recommended as a strategy to aid comprehensi-
bility [39]. McDougall and colleagues [1] found that their
participants (older adults of ethnic and racial minorities)
with visual and hearing deficits preferred PowerPoint pre-
sentations with large graphics, few words, and animation.
People with hearing problems could more easily discern
meanings if they could see as well as hear information.
Taub and colleagues [63] confirmed the usefulness of a
multi-step approach, using a comprehension test as part
of the informed consent process with elderly participants.
Cultural sensitivity
It is important to have a clear understanding of the special
circumstances of older CALD adults, which will differ ac-
cording to the particular CALD group [64], including of
their cultural-historical background [50] and socio-political
conditions [59]. Researchers must be mindful to use cultur-
ally appropriate language [3, 6], avoid language that may be
stigmatising for some groups [1], or adopt symbolic ges-
tures where appropriate [49], and they demonstrate an ap-
propriate attitude of openness and respect for differences
that is exclusive of stereotypes, prejudices, and biases [50],
while also making provision for possible adaptations based
on cultural differences [65]. For example, some groups re-
spond more favourably to personalised or direct, person-
to-person recruitment strategies [19, 21, 23].
Employing researchers and staff reflective of the com-
munity, as well as employing bilingual, bicultural staff,
enhances participation [6, 17, 57]. The process of gain-
ing, building, and maintaining trust is easier with older
CALD people when a researcher and respondent are
from the same background [23]. This was also a key
strategy identified by Sheppard and colleagues [66] in
their six studies on recruiting Latinos into cancer re-
search in the United States. They reported very high suc-
cess rates for recruitment (96 % on average). Other
strategies employed by this team included the following:
working in Latino places of social interactions, using
high-profile community leaders to disseminate informa-
tion (e.g. through media), simplifying and improving
comprehension in the informed consent process, and
emphasising culturally important ideas such as the sig-
nificance of the family in Latino culture.
Improving the consent process for CALD participants
has been the focus of several studies. Some CALD
groups favour verbal information over written [67] and
may see verbal consent as equivalent to written consent
[48]. A UK study found that obtaining informed consent
from CALD persons using audio recordings was accept-
able for the participants, and posed no difficulties [67].
In a linked study conducted in Bangladesh, use of audio
recording for the consent process encouraged individuals
with low literacy levels to participate in research [68]. In-
deed, some institutions now recommend the use of audio
for collecting data from minority ethnic communities [67].
Hernandez and colleagues [69] urge researchers to con-
sider employing a waiver of signed consent of participants
when conducting research in immigrant communities.
Avoiding written signed consent may be more appropriate
for participants with limited literacy or a lack of education,
or in cases where the preferred language modality is oral.
Another approach for documenting consent, which has
been suggested as potentially more acceptable in given
communities, is witnessed consent [47].
Facilitate access to research studies
In minority groups, mobility and safety concerns influence
whether or not a person feels comfortable, or even able, to
participate in a research study. Conducting research within
a community space or offering home visits has helped with
recruiting and retaining research participants [1, 3, 19, 57,
58]. Other options include taking the study to the local
neighbourhood of the target group and to places where the
participants live and congregate (e.g. grocery stores and re-
creation centres) [18]. Other strategies to improve access,
including providing incentives and reimbursement (for
travel/parking) [1, 6], providing transportation [19, 58], or
even providing childcare [19], which can be very helpful
strategies for communities where economic constraints are
a barrier to research participation. However, introducing
monetary incentives does raise ethical issues, as it may exert
an unfair influence on some populations [70]. Flexible
scheduling is an important consideration to combat the
time-constraint barrier [3] and has been successfully imple-
mented to improve enrolment and retention rates [1].
Awareness raising amongst researchers and other
stakeholders of barriers to CALD participation
Ford and colleagues concluded that ‘Because opportun-
ity barriers largely reflect protocol design as well as the
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process of study implementation, investigators play a
major role in determining the extent to which trials are
accessible to underrepresented groups’ (p. 238) [10].
Doctors, researchers, and ethics committees have a
crucial role to play in increasing the participation of
CALD groups in clinical research, while still adequately
protecting participants [25, 31]. Informed consent pro-
cesses need to be revisited and adapted for CALD
groups. It has been suggested that ‘less rigid study de-
signs’ (p. 238) and systems that facilitate the participa-
tion of healthcare providers are ways to create
conditions that will improve the recruitment of under-
represented populations to trials [10]. Modified consent
processes need to be developed to meet the needs of
participants for comprehensibility and ease of use, while
retaining ethical rigour. Nesting trials of innovative
methodologies aimed at increasing recruitment within
existing studies has been suggested as an effective way
to test the robustness of new methods [71].
The use of multimedia to improve CALD participation in
research
Researchers have attributed success in the recruitment of
minority groups to a multifactorial methodology [20] and
to the use of ‘an array of recruitment strategies’ [9]. One
problem is that engaging CALD communities requires sig-
nificant resources, not the least of which is financial, that
are rarely available in current research structures. Incorp-
orating multimedia technology may be less costly in the
long run and more sustainable than current practices that
require interpreters. An electronic resource can be cus-
tomisable to accommodate multiple languages and can be
developed incorporating principles of cultural sensitivity.
In addition, multimedia could be used by researchers who
do not necessarily speak the language of the participant.
Furthermore, multimedia resources may have key roles
to play in addressing health research literacy by explaining
medical research, enabling researchers to assess compre-
hension through testing, and improving CALD patient
comprehension of consent forms and procedures [38]. In
addition, technology offers possibilities to overcome
lengthy and burdensome patient information sheets, a
known source of patient dissatisfaction [71]. The findings
from trials of electronic resources to improve consent pro-
cesses, even if only with non-CALD participants, can in-
form the development of resources for CALD groups.
Methods combining textual, audio, and graphic (static
and/or dynamic) modes are increasingly being used in
many settings. Simultaneously combining more than one
mode (e.g. text and graphics) is associated with increased
comprehension, learning, and retention than text alone,
and splitting incoming information across more than one
cognitive channel (e.g. audio and visual) is associated with
significant learning gains [72].
Some reviews of clinical research using multimedia to
enhance understanding of information and consent
forms have reported inconsistent or minimal evidence of
improvements using newer technologies [40, 45, 73],
and proposed benefits to the willingness to participate
and participant satisfaction have been either inconclusive
or not apparent [73]. Conclusions have been limited due
to novelty, inconsistent methodologies, and definitions
[42]. In spite of these limitations, favourable conclusions
concerning the effectiveness of multimedia in the in-
formed consent process have also been drawn. Improved
outcomes for participant comprehension [41, 74, 75], for
both immediate information recall [76, 77] and delayed
recall [78], participant satisfaction (particularly regarding
understanding) [41, 79, 80], and reduced patient anxiety
levels [78, 79] have all been attested in both systematic
reviews and individual studies of multimedia approaches
to consent procedures conducted with fluent English
speakers. In addition, when consulted, participants have
indicated a preference for incorporating multimedia in
consent protocols [42].
In individual studies on consent procedures where the
only difference was the medium used, patients generally
preferred electronic over paper-based questionnaires in
spite of the fact that the former took longer to complete
[81, 82], perhaps because they had to be filled out com-
pletely in order for patients to finish them (which is in
itself advantageous from a researcher perspective).
A few studies adopting interactive approaches, for ex-
ample, where participants are required to demonstrate
their understanding by answering a quiz after watching a
video on an iPad or computer, show particular promise
for improving the comprehension and retention of know-
ledge regarding research in participants [54, 83] and in-
creasing participant interest in taking part in a study [76].
Acceptability of an electronic tablet resource to older
CALD people
Some questions exist concerning the acceptability of
using an electronic resource with older people. Nonethe-
less, one study comparing the use of a tablet-based
screening procedure with an integrated voice response
system for recruitment and screening of patients into
pragmatic clinical trials concluded that the tablet was
‘highly accepted by older patients’ [35]. Shneerson et al.
[45] designed a questionnaire to elicit views from older
cancer patients, their carers, friends, and families on the
provision and design of multimedia resources used to
deliver clinical trials information. Most respondents,
whose average age was over 60, indicated that seeing a
multimedia resource might encourage them to find out
more about clinical trials, and more than half preferred
a ‘more practical learning mode, as could be delivered
via multimedia resources’. Preferred devices were mobile
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phones, laptops, and DVD players, although Shneerson
concluded that ‘from a practical perspective tablet tech-
nologies would appear to be the most suitable delivery
medium, being portable, cheap, less prone to operating sys-
tem errors and simple to use’, and felt that the transition
from PCs (with which they were familiar) to tablets would
be relatively easy with suitable training and support.
A study evaluating user response to a talking touchsc-
reen, introduced as a means to improve health literacy
in underserved U.S. populations, found that most users,
the majority of whom were computer-naïve, rated the
design of the screen highly and found it easy to use [84].
It is important to take into account, nonetheless, that in
some cases, there may be a correlation between difficulty
filling out a questionnaire on a tablet and CALD back-
ground, increased age, lower levels of education, and co-
morbid medical conditions [85]. Furthermore, research
into barriers to participation underlines the importance,
for participants, of a human connection [21].
Conclusions
A main finding of this review is that addressing the obsta-
cles to CALD participation in clinical research requires a
complex, multi-methodological approach. A further aid to
help eliminate barriers, we believe, lies in incorporating
multimedia tools in this approach. To be effective, such
tools need to form part of a culturally sensitive system,
which we propose would include providing resources in
the preferred languages of potential participants, and tai-
loring them to target communities’ language, literacy, and
cultural needs. We envisage that it would always be pref-
erable to have a researcher present with a participant, both
to help with using the device, and also to be a tangible hu-
man presence.
Nonetheless, another important finding of this review
has been to emphasize the fact that the ultimate success
of any initiatives in the area of CALD inclusion in clin-
ical research is contingent on the willingness of stake-
holder groups, and notably ethics review boards, to
participate in and co-operate with the creation of novel
processes or the adaptation of existing processes, espe-
cially concerning consent. This would create the condi-
tions needed to make the participation of CALD groups
in clinical research a reality. We recommend that future
work in the area focus on this key issue.
Endnotes
1The term CALD is used in the current study. However,
the term is used interchangeably with ‘migrant’ or ‘ethnic’
in the context of comparisons with other studies.
Abbreviations
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